Bosh sahifa300601 • SHE
add
Shenzhen Kangtai Biological Prods Co Ltd
Yopilish kursi
15,59 ¥
Kunlik diapazon
15,31 ¥ - 15,67 ¥
Yillik diapazon
13,10 ¥ - 21,12 ¥
Bozor kapitalizatsiyasi
17,49 mlrd CNY
Oʻrtacha hajm
12,41 mln
Narx/foyda
-
Dividend daromadliligi
0,58%
Asosiy maydon
SHE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 671,38 mln | -17,74% |
Joriy xarajat | 425,29 mln | -2,76% |
Sof foyda | 11,62 mln | -93,74% |
Sof foyda marjasi | 1,73 | -92,40% |
Har bir ulushga tushum | — | — |
EBITDA | 212,79 mln | -40,14% |
Amaldagi soliq stavkasi | -3 472,08% | — |
Balans
Jami aktivlari
Jami passivlari
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,65 mlrd | 431,20% |
Jami aktivlari | 14,13 mlrd | -2,63% |
Jami passivlari | 4,52 mlrd | -5,87% |
Umumiy kapital | 9,61 mlrd | — |
Tarqatilgan aksiyalar | 1,12 mlrd | — |
Narxi/balansdagi bahosi | 1,81 | — |
Aktivlardan daromad | 2,39% | — |
Kapitaldan daromad | 2,94% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (CNY) | sen, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 11,62 mln | -93,74% |
Operatsiyalardan naqd pul | 286,87 mln | 60,54% |
Sarmoyadan naqd pul | 676,05 mln | 357,44% |
Moliyadan naqd pul | -44,23 mln | -4,17% |
Naqd pulning sof oʻzgarishi | 918,51 mln | 825,91% |
Boʻsh pul | -1,08 mlrd | 43,85% |
Haqida
Shenzhen Kangtai Biological Products, also known as BioKangtai, is a Chinese biopharmaceutical company that develops, manufactures and markets vaccines and other vaccine products.
Kangtai develops the Minhai COVID-19 vaccine and has the exclusive right to manufacture the Oxford–AstraZeneca COVID-19 vaccine in mainland China. Wikipedia
Tashkil etilgan
8-sen, 1992
Sayt
Xodimlar soni
1 913
